Vanguard Growth ETFs Compared: Should You Go for Megacap or Small-Cap Growth Stocks to Finish Out 2026?

Vanguard’s MGK and VBK both charge a low 0.05% expense ratio, but they tilt differently: MGK is concentrated in technology (72%) across 56 holdings (notably Nvidia 13.55%, Apple 13.22%, Microsoft 9.52%), while VBK is more diversified with 543 holdings (technology 23%, industrials 22.6%, healthcare 18.8%). Over the last 5 years, MGK shows higher total growth ($1,882 vs. $1,268 over $1,000 initial), but VBK leads on 1-year performance (+23.4% vs. +17.5%) and has a higher dividend yield (0.4% vs. 0.3%). The risk profile is broadly similar with max drawdowns of -38.4% (VBK) vs. -36.0% (MGK) over 5 years, implying the choice is primarily driven by desired market-cap exposure and portfolio concentration.

Analysis

The real signal here is not “growth is good,” but that investors are being nudged to choose between a crowded, duration-sensitive megacap basket and a much less owned breadth play. MGK is effectively a high-conviction proxy for AAPL/MSFT/NVDA concentration; that helps in risk-on tape, but it also means marginal disappointment in AI capex, iPhone cycles, or cloud growth can hit the ETF more than the headline dispersion suggests. VBK’s broader exposure makes it a cleaner beneficiary if the market starts rewarding breadth over concentration, especially if rates drift lower and small-cap funding conditions improve.

The second-order effect is flow, not fundamentals: if this comparison resonates, the incremental bid likely goes to smaller growth names that are under-embedded in passive portfolios, while the megacap complex loses a bit of its “must-own” halo. That matters most for names like CRDO, NTRA, and RVMD, where index ownership can support liquidity and valuation rerating; it matters less for NVDA/MSFT/AAPL, whose terminals are driven by earnings revisions and AI spending, not ETF article traffic. Over 1-3 months, the setup favors relative breadth trades more than outright beta bets.

Contrarian view: the article’s performance framing may be stale. MGK has the stronger multi-year compounding engine because the market keeps paying for earnings durability and buyback support, so the burden of proof is on VBK to sustain outperformance once the rate-cut tailwind fades. The risk to a VBK-over-MGK call is that small-cap growth remains vulnerable to financing costs and earnings misses, while megacaps can absorb macro noise. Falsification would be a renewed widening in large-cap earnings revisions or a rise in real yields, both of which would reassert concentration leadership.

Key Decisions for Investors

• Prefer VBK over MGK only as a tactical 1-3 month breadth trade: initiate a small relative-value long VBK / short MGK pair on any pullback in mega-cap tech, with a stop if NVDA/MSFT earnings revisions accelerate again.
• Use MGK as a hedge for crowded single-name long exposure to AAPL/MSFT/NVDA; if already long those names individually, avoid adding MGK because you are paying for redundant concentration.
• Watch CRDO/NTRA/RVMD for flow-driven upside over 1-2 months; if breadth improves and rates ease, these names can outperform their index weights even without fundamental news.
• If real yields move higher or the Fed turns more hawkish, fade VBK and rotate back toward MGK; that regime change would likely invalidate any small-cap growth leadership thesis within weeks.
• No aggressive options trade here unless there is confirmation from rates or earnings: the article itself is too low-signal to justify premium-buying absent a catalyst.